Humana (HUM) Liabilities and Shareholders Equity (2009 - 2026)

Humana (HUM) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $57.2 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 13.58% year-over-year to $57.2 billion; the TTM figure through Jun 2026 stood at $211.1 billion (up 6.74% YoY), while the FY2025 annual figure was $48.9 billion, up 5.23% from the prior year.
• Liabilities and Shareholders Equity improved to $57.2 billion in Q2 2026 per HUM's latest filing, from $55.3 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $57.2 billion in Q2 2026 and bottomed at $43.1 billion in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $50.6 billion across 5 years, with a median of $50.1 billion in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity increased 23.77% — and 2024, when it fell 11.27%.
• Humana's Liabilities and Shareholders Equity stood at $43.1 billion in 2022, then rose by 9.31% to $47.1 billion in 2023, then fell by 1.25% to $46.5 billion in 2024, then grew by 5.23% to $48.9 billion in 2025, then grew by 16.94% to $57.2 billion in 2026.
• Business Quant data shows HUM's Liabilities and Shareholders Equity at $57.2 billion in Q2 2026, $55.3 billion in Q1 2026, and $48.9 billion in Q4 2025.